Topics

Q BioMed Regains Non-Opioid Cancer Pain Medicine, Hires Commercial Team

20:00 EDT 2 Oct 2019 | BioSpace

Under terms of the global royalty agreement, Q BioMed will assume immediate ownership of the pain asset, as well as an abbreviated new drug application for the treatment.

Original Article: Q BioMed Regains Non-Opioid Cancer Pain Medicine, Hires Commercial Team

NEXT ARTICLE

More From BioPortfolio on "Q BioMed Regains Non-Opioid Cancer Pain Medicine, Hires Commercial Team"

Quick Search

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Pain Disorder
Pain is a feeling (sharp or dull) triggered in the nervous system which can be transient or constant. Pain can be specific to one area of the body eg back, abdomen or chest or more general all over the body eg muscles ache from the flu. Without pain ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...